Peter P. Pfreundschuh Voyager Therapeutics, Inc. (VYGR) insider trading activity

Peter P. Pfreundschuh is Chief Financial Officer of Voyager Therapeutics, Inc.. Currently has a direct ownership of 175,669 shares of VYGR, which is worth approximately $1.23 Million. The most recent transaction as insider was on Feb 21, 2024, when has been sold 3,764 shares (Common Stock) at a price of $7.46 per share, resulting in proceeds of $28,079. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 176K

0% 3M change

17.56% 12M change

Total Value Held $1.23 Million

PETER P. PFREUNDSCHUH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 21 2024	SELL Open market or private sale	$28,079 $7.46 p/Share	3,764 Reduced 2.1%	175,669 Common Stock
Feb 09 2024	BUY Grant, award, or other acquisition	-	30,000 Added 14.32%	179,433 Common Stock
Oct 03 2023	SELL Open market or private sale	$94,833 $6.99 p/Share	13,567 Reduced 8.32%	149,433 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	38,000 Added 18.91%	163,000 Common Stock
Oct 01 2022	BUY Grant, award, or other acquisition	-	125,000 Added 50.0%	125,000 Common Stock

Also insider at

URGN

UroGen Pharma Ltd. Healthcare

Chief Financial Officer

FREQ

Frequency Therapeutics, Inc. Healthcare

Chief Financial Officer

YMAB

Y-mAbs Therapeutics, Inc. Healthcare

CFO and Treasurer

PPP